Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rukman Thota"'
Autor:
Spencer E Brightman, Angelica Becker, Rukman Thota, Martin S Naradikian, Ryan Griswold, Joseph S Dolina, Stephen P Schoenberger
Publikováno v:
The Journal of Immunology. 208:180.06-180.06
The expansion of neoantigen (NeoAg)-specific T cells often accompanies clinical responses to immunotherapies such as immune checkpoint blockade (ICB), adoptive cellular therapy (ACT), and personalized cancer vaccines (PCV), highlighting their importa
Autor:
Martin S. Naradikian, Leslie Montero, Samantha Hall, Milad Bahmanof, Rukman Thota, Luise Sternberg, Jerome Lane, Zeynep Kosaloglu-Yalcin, Manasa Lanka, Aaron Miller, Bjoern Peters, Ezra Cohen, Stephen Schoenberger
Publikováno v:
Cancer Research. 79:1439-1439
Neoantigens (NeoAg) offer attractive therapeutic targets for directing a patient’s immune response to the immunogenic subset of mutations expressed exclusively by their cancer cells. Despite the specificity with which NeoAg enable tumor recognition
Autor:
Martin Souren Naradikian, Leslie Montero, Samantha Hall, Rukman Thota, Angela Frentzen, Milad Bahmanof, Luise Sternberg, Jerome Lane, Zeynep Kosaloglu-Yalcin, Manasa Lanka, Aaron Miller, Bjoern Peters, Ezra Cohen, Stephen Schoenberger
Publikováno v:
The Journal of Immunology. 202:134.1-134.1
Neoantigens (NeoAg) offer attractive therapeutic targets for directing a patient’s immune response to the immunogenic subset of mutations expressed exclusively by their cancer cells. Despite the specificity with which NeoAg enable tumor recognition